DISCOUNT-ZERTIFIKAT - NOVARTIS N Share Price

Certificat

DE000SQ6L3G4

Delayed Deutsche Boerse AG 10:14:19 06/06/2024 pm IST
69.83 EUR +0.04% Intraday chart for DISCOUNT-ZERTIFIKAT - NOVARTIS N
Current month+0.03%
1 month+0.35%
Date Price Change
06/24/06 69.83 +0.04%
05/24/05 69.8 0.00%
04/24/04 69.8 +0.01%
03/24/03 69.79 +0.01%
31/24/31 69.78 +0.01%

Delayed Quote Deutsche Boerse AG

Last update June 06, 2024 at 10:14 pm IST

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying NOVARTIS AG
IssuerLogo Issuer Société Générale Société Générale
WKN SQ6L3G
ISINDE000SQ6L3G4
Date issued 20/12/2022
Cap 66.38 CHF
Last trading day 20/06/2024
Maturity 21/06/2024 (15 Days)
Parity 0.95 : 1
Emission price 64
Emission volume N/A
Payment day 28/06/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 0.000000 %
Sideways yield 0.000000 %
Sideways yield pa 0.000000 %
Outperformance point- CHF
Break even 0.000000 €
Highest since issue 69.89
Lowest since issue 63.09
Spread 0.13
Spread %0.19%
Distance Cap 28.61 CHF
Distance Cap %+30.12%
Max. earning-
Max. earning % 0.000000 %

Company Profile

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales (excluding discontinued operations) break down by therapeutic area as follows: - oncology (29.9%); - immunology (17.2%); - cardiovascular, renal and metabolic diseases (14.1%); - neuroscience (8.9%). The remaining net sales (29.9%) are from contract manufacturing of pharmaceutical products. At the end of 2023, Novartis AG had 33 production sites worldwide. Net sales are distributed geographically as follows: Europe (33%), the United States (39.5%), Asia/Africa/Australasia (20.5%), Canada and Latin America (7%).
Sector
-
More about the company

Ratings for Novartis AG

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Novartis AG

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
105.7 USD
Average target price
110.1 USD
Spread / Average Target
+4.20%
Consensus